Bacterial vaginosis, Prevotella species, and Bacteroides species have been associated with prematurity and upper genital tract infection. Prevotella (Bacteroides) species and Bacteroidesfragilis have also been associated with preterm birth. However, the mechanism by which lower genital tract infection causes upper genital tract disease remains poorly understood. Sialidases (neuraminidases) are enzymes which enhance the ability of microorganisms to invade and destroy tissue. Elevated levels of sialidase activity were detected in 42 (84%) of 50 vaginal fluid specimens from women with bacterial vaginosis and none of 19 vaginal fluids from women without bacterial vaginosis (P < 0.001). Vaginal fluid from women with bacterial vaginosis had a median specific activity of 9.8 U compared to 2.5 U of sialidase in women without bacterial vaginosis (P < 0.001). In order to determine the probable source of sialidases in vaginal fluid, the microorganisms recovered from women with bacterial vaginosis before and after treatment were assayed. Of 28 specimens from women with bacterial vaginosis, 27 (961%) yielded sialidase-positive bacteria, at a median concentration of 106.5 CFU/ml of vaginal fluid. PrevoteUla and Bacteroides species accounted for the sialidase activity in 26 of the vaginal fluids, and GardnereUla vaginalis accounted for the sialidase activity in the remaining fluid. After treatment, sialidase was detected in the vaginal fluid of 1 (5%) of 22 women who responded to therapy and in all of 6 women for whom therapy failed. These data suggest that vaginal fluid sialidase is highly correlated with bacterial vaginosis and that the probable sources for this enzyme activity are the Bacteroides and PrevoteUla species present in the vagina.
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Bacterial vaginosis (BV) is a syndrome defined microbiologically by decreased numbers of Lactobacillus spp. and increased numbers of Gardnerella vaginalis, Bacteroides spp., Prevotella spp., Mobiluncus spp., Peptostreptococcus species, and Mycoplasma hominis (7, 22) . Accumulating evidence indicates that BV may be a risk factor for histologic chorioamnionitis (6) , amniotic fluid infection (26, 29) , postcesarean endometritis (29) , and prematurity (14) . Furthermore, three studies have linked vaginal Prevotella and Bacteroides spp. with preterm delivery (9, 15, 18) . Although published data suggest that both BV and vaginal gramnegative anaerobic rods are risk factors for pregnancy complications (9, 14-16, 18, 26, 29) , the pathogenesis remains poorly understood.
Several bacterial enzymes, including phospholipases and proteases, have been suggested as potential virulence determinants in prematurity (16, 17) . Sialidases, formerly known as neuraminidases, are enzymes which cleave alpha-ketosidic linkages between the glycosyl residues of glycoproteins, glycolipids, or colominic acids and sialic acids. Sialidases have been implicated as virulence factors in several pathogenic organisms, including Corynebacterium diphtheriae and Vbrio cholerae (24) , Streptococcus pneumoniae (8) , and group B streptococci (2) . Published data suggest that some of the organisms associated with bacterial vaginosis may also produce sialidases. Sialidase activity has been detected in anaerobic rods formerly included in the genus Bacteroides (25a), including Prevotella bivia, Prevotella disiens, black-pigmented Prevotella and Porphyromonas species, and Bacteroides fragilis group isolates (20) . Sialidase * Corresponding author. activity was detected in 1 of 10 clinical isolates of G. vaginalis (28) . Previous studies have demonstrated that several Mycoplasma spp. are able to use sialic acid receptors for adsorption (12, 13) . However, in these investigations, isolates of M. hominis were not assayed for sialidase activity. Finally, no study to date has examined whether Mobiluncus or Peptostreptococcus species have sialidases. The association of sialidase activity with BV had not been previously examined.
The aims of this investigation were to assay vaginal fluid for sialidase activity and to compare the levels of sialidase activity in the vaginal fluid of women with BV with those detected in the vaginal fluid collected from women characterized as not having BV. In order to identify the probable source of the enzyme activity in vaginal fluid, vaginal isolates from women with BV, before and after treatment, were tested for sialidase activity. Vaginal wash specimens were prepared by inserting a sterile, nonlubricated speculum, washing the vaginal walls with 3.5 ml of prereduced saline, and removing the resultant suspension with a sterile syringe. The vaginal wash specimens from 28 of the women with BV were diluted serially 1:10 and inoculated onto prereduced brucella agar supplemented with hemin, vitamin K, and 5% sheep blood for recovery of anaerobic gram-negative rods and onto human blood bilayer Tween agar for recovery of G. vaginalis as previously described (9) . The remaining 22 vaginal wash specimens from women with BV and 19 specimens from women without infection were used for the quantitative assay of sialidase activity. To presumptively identify the source of sialidase activity among the microorganisms associated with BV, stocked culture isolates of P. bivia, P. disiens, Mobiluncus spp., M. hominis, Peptostreptococcus spp., and G. vaginalis collected during previous studies were assayed.
MATERIALS
Sialidase activity was qualitatively determined by a filter paper spot test which has been described previously (19 
RESULTS
When assayed by the spot test, 42 (84%) of 50 specimens from women with BV were positive for sialidase activity, compared to none of 19 specimens from women with normal vaginal flora (P < 0.001 by Fisher's exact test). Because of limitations in the quantity of vaginal wash specimens available from each woman, 41 vaginal fluid specimens (22 from women with BV and 19 from women with normal vaginal flora) were used for the quantitative measurement of sialidase activity. The remaining 28 washes from women with BV were assayed for sialidase by the spot test and inoculated onto plates for quantitative culture.
The specific activity of sialidase detected in vaginal washes from women with BV versus controls is shown in Fig. 1 . The median sialidase activity among women with BV was 9.8 U (mean, 12 .0 + 8.1 U) versus 2.5 U (mean, 3.5 ± 3.6 U) in women without BV (P < 0.001 by the nonparametric median test). Specimens having less than 7 U of sialidase activity were negative for sialidase by the spot test.
In order to identify the probable source of sialidase activity among women with BV, pure stock-culture isolates of P. bivia, P. disiens, G. vaginalis, Mobiluncus curtisii, Mobiluncus mulieris, Peptostreptococcus species, and M.
hominis were tested for sialidase activity. All of the 83 P. bivia isolates were positive for sialidase activity, compared with 12 (38%) of 32 P. disiens isolates. Twenty-one (20%) of 105 G. vaginalis isolates assayed were positive for sialidase activity. Isolates of G. vaginalis from women without BV were as likely to be positive for sialidases as isolates from women with BV (data not shown). None of the 10 M. hominis or 10 Mobiluncus species isolates tested were positive for sialidase activity. Four isolates each of Peptostreptococcus asaccharolyticus, Peptostreptococcus anaerobius, Peptostreptococcus magnus, Peptostreptococcus prevotii, and Peptostreptococcus tetradius were also negative for sialidase activity. These data suggested that anaerobic gram- Repeat vaginal cultures were obtained from the 28 women 1 to 3 weeks following completion of therapy with metronidazole or ampicillin. In addition, the vaginal fluid was tested for sialidase activity. Twenty-two (79%) of the women were clinically cured at follow-up (no clue cells, pH of c4.5, and no amine odor), and six had persistent BV (Table 1) . Sialidase activity was detected in 1 (5%) of 22 vaginal specimens from women who had responded to therapy. Seven of the specimens from women who were free of BV following treatment and who did not have detectable sialidase in the vaginal fluid had sialidase-positive P. bivia recovered from the vaginal cultures (Table 1 ). In six of seven instances, P. bivia was present at concentrations of <105 CFU/ml, and in the remaining specimen P. bivia was present at 107 CFU/ml. Thus, the presence of detectable sialidase in the vaginal fluid was usually correlated with >1i CFU of sialidase-positive, anaerobic, gram-negative rods per ml.
All of the six specimens from women who failed therapy were positive for sialidase; four specimens yielded P. bivia at a median concentration of 106.8 CFU/ml, and the remaining two specimens yielded B. fragilis at 108-0 CFU/ml and a Prevotella species at 109 CFU/ml.
At a third follow-up 1 month after therapy, six women developed recurrent BV. Sialidase was detected in all of the vaginal fluid specimens, and sialidase-positive P. bivia and P. disiens were present at a median concentration of 107-3 CFU/ml.
DISCUSSION
The aims of this investigation were to determine whether sialidases in vaginal fluid were associated with BV and to identify which organisms recovered from women with BV contributed sialidase activity to the vaginal fluid. In this study, we demonstrated that 84% of women with BV have detectable sialidases in their vaginal fluid and that the specific activity is higher in these women than in women without the syndrome. Our data further implicate anaerobic gram-negative rods belonging to the genera Prevotella and Bacteroides as the major source of sialidase activity in the vaginal fluid.
Prevotella (formerly Bacteroides) species at concentrations of 107 to 108 CFU/ml of vaginal fluid can be recovered from the vaginae of 94% of women with BV (4). In the present study, clinical cure was associated with an 88% reduction of sialidase activity in the vaginal fluid and a 64% reduction in the frequency of sialidase-positive vaginal bacteria, as well as a 100-fold decrease in their concentration. Conversely, clinical failure was correlated with persistence of vaginal fluid sialidase and the persistence of sialidasepositive anaerobes in the vaginal fluid. These data suggest that the presence of sialidase activity in the vaginal fluids of women with BV is associated with the presence of sialidasepositive Prevotella and Bacteroides species. Prevotella and Bacteroides species are able to ascend into the upper genital tract to cause infection during pregnancy. Women with BV are significantly more likely to develop intraamniotic infection (26) and postpartum endometritis (29) . Vaginal colonization with Prevotella species has been linked to an increased risk of preterm delivery and preterm premature rupture of membranes in two studies (15, 18) . In a recent study, P. bivia, isolated from the vagina at concentrations greater than 104 CFU/ml of vaginal fluid, was associated with a twofold increased risk of preterm delivery among women in preterm labor (9) . P. bivia has been recovered from the amniotic fluid of 46% of women with intra-amniotic infection who delivered low-birthweight infants (27) . B. fragilis in the vagina has also been linked to an increased risk of preterm birth (9) . Anaerobic gram-negative rods have also been recovered from the chorioamnion and are associated with histologic chorioamnionitis (5) .
The production of sialidase by the anaerobes associated with prematurity suggests that the enzyme may be involved in their pathogenesis. Studies have demonstrated that exposure of tissues to sialidases eliminates subterminal sugars, resulting in an increased adherence capability by certain bacteria (3, 25) . Since both cervical mucus and amniotic fluid have been demonstrated to contain significant amounts of sialic acid (10, 21) , sialidases may promote virulence by enhancing the ability of these organisms to adhere to, invade, and destroy mucosal tissue. Bacterial sialidases also decrease collagen synthesis in fibroblasts (1) .
The other microorganisms associated with BV include G. vaginalis, Mobiluncus spp., Peptostreptococcus spp., and M. hominis (7, 14) . In the present study, these genera did not usually produce detectable sialidase activity. G. vaginalis accounted for the vaginal sialidase activity in only 1 of 28 women with BV.
Further studies are needed to determine whether there is a relationship between sialidase activity in vaginal fluid and VOL. 30, 1992 on October 28, 2017 by guest http://jcm.asm.org/ Downloaded from prematurity, upper genital tract infection, and BV. It will be of interest to determine whether sialidases in the vaginal fluid of pregnant women are associated with an increased risk of preterm labor or invasion of the amniotic cavity.
